ClinicalTrials.gg
RecruitingNCT07729891RECOVERUpdated Jul 28, 2026

Real-time Evaluation and Continuous Observation of Vital Signs for Enhanced Recovery: a Study for the Early Identification of Complications in the Surgical Ward Following Surgery in Patients Not Eligible for Intensive Care Admission.

An observational study in Postoperative Complication, Respiratory Complications and Cardiac Complications, sponsored by Azienda Ospedaliero-Universitaria di Parma. Recruiting at 1 site in Italy. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-07-28.

Sponsored by Azienda Ospedaliero-Universitaria di Parma · Observational

How we know

From the registry’s dates

  • Started Feb 2026; still recruiting 9 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
150
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 59 studies in Postoperative Complications with a site in Italy — 16 open to participants now, 18 under way, 1 of them phase 3. Postoperative Complications · Italy.

Planned enrollment
18th of 23
150 · median 500
Started
2026
with 7 others
Observational
23 of 59
8 open now
Primary completion
2027-02
later than 10 of 17 live
Registered
55th of 59
by date
Lead sponsor
3 of 59
Azienda Ospedaliero-Universitaria di Parma

Among the 59 studies in Postoperative Complications with a site in Italy, this one is the 18th largest by planned enrollment of the 23 observational ones that give a count, is one of 8 that started in 2026, is one of 23 observational ones, reaches primary completion later than 10 of the 17 other live ones, and was the 55th registered.

Postoperative Complications

1,343 studies on the registry are indexed under Postoperative Complications; 314 are open to participants now.

Browse Postoperative Complications studies →

Open to participants now

16 of the 59 studies in Postoperative Complications with a site in Italy are open now. Recruiting first, the newest first:

10 more — sign in →

All 16 open studies →

A study can be open while its sites in Italy have not opened yet or have stopped. Only those recruiting at a site in Italy →

Who these studies take

Of the 200 Postoperative Complications studies recruiting now, 126 (63%) set no upper age limit and 31 (16%) stop at 75 or younger; 24 take children under 18; 25 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 59 studies in Postoperative Complications with a site in Italy, or all of them as a file.
02

Study summary

This study aims to evaluate whether continuous vital sign monitoring with wearable devices can help detect postoperative complications in surgical ward earlier than standard hospital monitoring. In particular, the goal of this observational study is to evaluate if the wireless wearable devices Portrait Mobile (GE Healthcare) can detect early signs of complications after major urologic surgery in adults who are not eligible for intensive care unit admission. The main questions it aims to answer are:

  • Can continuous monitoring of vital signs (heart rate, breathing rate, blood oxygen) detect health problems earlier than standard nurse checks in the urology ward?
  • How many times do participants' vital signs change in ways that suggest a complication is developing during the first days after surgery?
  • Does the vital sign trend and/or the deviation from patients' baseline suggest a complication is developing during the first days after surgery?
  • Does continuous monitoring help healthcare providers intervene before patients become critically ill thus reducing complications burden or severity and reducing unplanned intensive care admission? Participants in the intervention cohort will wear a wireless patch-like device on their chest that continuously tracks their heart rate, breathing rate, and blood oxygen levels. The device sends this information to hospital staff through a secure wireless connection while participants recover in the regular urology ward after surgery. Participants in the intervention cohort will wear the device for 3 days after surgery or until they leave the hospital. Healthcare providers will receive alerts if vital signs change in ways that suggest a complication may be developing. This may help providers treat problems earlier and prevent patients from becoming critically ill. All participants will also receive standard post-surgical care, including regular nurse checks of vital signs.
Read the detailed description

The RECOVER study evaluates the use of continuous wearable monitoring in surgical ward for the early detection of postoperative complications in patients recovering after major surgery. The study begins with the evaluation of urologic surgery. It focuses on whether continuous measurement of vital signs in the surgical ward can identify clinical deterioration and postoperative complications earlier than routine postoperative surveillance alone: postoperative complications are often preceded by changes in vital signs and may develop during the first days after surgery, when patients are usually monitored intermittently in the ward. Continuous wireless monitoring is intended to provide earlier recognition of respiratory and hemodynamic deterioration while patients recover outside the operating room and outside intensive care.

The main objective is to assess whether continuous monitoring of vital signs can detect early signs of medical or surgical postoperative complications after moderate-to-high complexity urologic surgery performed under general anesthesia. The protocol is particularly focused on identifying episodes of desaturation, tachypnea, hemodynamic instability, and persistent deviation of vital signs from patient's baseline values during the postoperative period.

Patient enrollment takes place in the Urology ward before the scheduled operation. During the preoperative anesthesiology evaluation, the anesthesiologist provides study information and asks the patient to participate by signing informed consent and personal data processing forms. This enrollment process is maintained in both patient pathways described in the protocol.

For patients managed with continuous monitoring, the wearable system is applied on the evening before surgery so that baseline vital sign values can be collected under resting conditions. Monitoring is interrupted before transfer to the operating room and restarted after the patient returns from surgery to the ward. The patient then wears the system for at least 72 hours after surgery, and the device does not replace standard postoperative monitoring.

The wearable platform used in the protocol is the Portrait Mobile® system by GE HealthCare. It continuously records respiratory rate, oxygen saturation, and heart rate, while blood pressure and EKG continues to be measured intermittently according to usual ward practice in order to maintain the non-intensive care settings and the actual patient-nurse ratio. Data are transmitted through the hospital Wi-Fi network to a dedicated monitoring infrastructure, where alarms can be visualized on the ward monitoring station.

Alarm thresholds are predefined by the investigator using values derived from the National Early Warning System Score. These thresholds include respiratory rate below 11 or above 21 breaths per minute, oxygen saturation below 95%, and heart rate below 50 or above 91 beats per minute. In addition to threshold-based events, the protocol evaluates persistent deviation from baseline, defined as a change greater than 20% for at least 24 hours, in order to capture clinically meaningful trends rather than isolated abnormal values.

When an alarm is generated, ward nursing staff are asked to determine whether the alert is appropriate or represents a false positive. They also record whether the patient is at rest or moving at the time of the alert, allowing the investigators to assess device performance under real clinical conditions. Subsequent clinical actions, including review by the ward physician, on-call physician activation, or request for anesthesiology consultation, are reconstructed from nursing handover and the clinical chart.

For patients managed with usual postoperative surveillance alone, enrollment still occurs during the preoperative anesthesiology assessment and clinical data are collected after informed consent is obtained. These patients receive standard ward monitoring without wearable continuous monitoring, and their postoperative course is documented for comparison of clinical events and outcomes.

The primary endpoints are the number of desaturation events, tachypnea events, and hemodynamic instability events. Secondary endpoints include false positive rate, number of physician alerts, number of requests for intensive care consultation, unplanned intensive care admission directly from the operating area, transfer to intensive care during postoperative ward stay, postoperative complications, re-surgery, correlation between parameter trends and outcomes, hospital length of stay, barriers to rehabilitation, patient satisfaction, and integration of the system with the hospital IT infrastructure.

All complications will be recorded in the case report form and graded according to the Clavien-Dindo classification. Collected data include baseline patient characteristics, average preoperative vital sign values, diagnosis, type of surgery, intraoperative data, continuous monitoring data, postoperative clinical course, pain, functional recovery, total hospital stay, ICU stay, and patient satisfaction with the monitoring system.

The system is not expected to expose patients to additional risk and does not interfere with the usual diagnostic and therapeutic pathway. Wireless wearable monitoring should not negatively affect mobilization, rehabilitation, or functional recovery, which is relevant because preservation of postoperative recovery is one of the practical concerns addressed by the study.

03

Conditions studied

  • Postoperative Complication
  • Respiratory Complications
  • Cardiac Complications

Keywords

  • postoperative
  • complications
  • intensive care unit admission
  • urology
  • wearable devices
  • continuous monitoring
  • surgical ward
  • wireless
  • medical emergency team
  • unplanned ICU admission
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Adult patients undergoing to major urological surgery performed under general anesthesia and without a planned intensive care unit admission.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Ability to give and consent to the processing of personal data by signing the relevant forms;
  • Aged over 18 years old
  • Medium-to-high complexity urological surgery without the need for post-operative monitoring in the Intensive Care Unit
  • Surgery performed under general anaesthesia
  • Discharge to the ward is scheduled upon leaving the operating theatre

Exclusion criteria

Exclusion Criteria:

  • Refusal or inability to consent to participation
  • Patients under 18 years old
  • Planned admission to Post-Operative Intensive Care Unit after the surgery
  • Unplanned admission to the Post-Operative Intensive Care Unit at the end of the surgery
  • Anaesthetic technique other than general anaesthesia.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
150 participants (estimated)
Patient registry
No

Groups and cohorts

  • Standard intermittent monitoring (Control)

    100 patients receiving standard intermittent nurse vital sign check

  • Wearable device continuous vital sign monitoring (Intervention)

    50 patients receiving wearable device continuous vital sign monitoring with Portrait Mobile (GE Healthcare). Parameters monitored: Heart Rate, SpO2, Respiratory Rate.

    Device: Continuous vital sign monitoring with Portrait Mobile in surgical ward

Interventions

  • DeviceContinuous vital sign monitoring with Portrait Mobile in surgical ward

    The wearable system is applied on the evening before surgery so that baseline vital sign values can be collected under resting conditions. Monitoring is interrupted before transfer to the operating room and restarted after the patient returns from surgery to the ward. The patient then wears the system for at least 72 hours after surgery. Respiratory rate, oxygen saturation, and heart rate are continuously collected, while blood pressure and EKG continues to be measured intermittently according to usual ward practice in order to maintain the non-intensive care settings and the actual patient-nurse ratio. Alarm thresholds are predefined by the investigator using values derived from NEWS and alarms calibrated over baseline parameters.

06

What researchers measure

Primary outcomes

  1. Number of event of desaturation

    An 'event' among the primary outcomes will be those used by the National Early Warning System Score (NEWS: Respiratory rate \<11 and \>21 breaths/min; SpO₂ \<95%; Heart rate \<50 bpm and \>91 bpm)

    Time frame: 72 hours after the surgery

  2. Number of event of tachypnoea or bradypnoea

    An 'event' among the primary outcomes will be those used by the National Early Warning System Score (NEWS: Respiratory rate \<11 and \>21 breaths/min; SpO₂ \<95%; Heart rate \<50 bpm and \>91 bpm)

    Time frame: 72 hours after the surgery

  3. Number of event of haemodinamic instability

    An 'event' among the primary outcomes will be those used by the National Early Warning System Score (NEWS: Respiratory rate \<11 and \>21 breaths/min; SpO₂ \<95%; Heart rate \<50 bpm and \>91 bpm)

    Time frame: 72 hours after the surgery

Secondary outcomes

  1. False-positive rate

    Number of alarms triggered without a real Event

    Time frame: 72 hours after the surgery

  2. Number of on-call doctor call-outs

    Nurse activation of the medical staff of the surgery ward

    Time frame: 72 hours after the surgery

  3. Number of requests for Anesthesia consultation

    Activation of Hospital medical emergency team

    Time frame: 72 hours after surgery

  4. Unscheduled direct admission to the Intensive Care Unit from the operating theatre and unplanned transfer to the Intensive Care Unit during the post-operative period (from the surgical ward)

    After Anesthesiological evaluation and activation of Hospital medical emergency team

    Time frame: 72 hours after surgery

  5. Occurrence of post-surgical complications (any type) or reoperation

    Any type of complication and their severity (Clavien Dindo score) that occur during the intervention period

    Time frame: 72 hours after surgery or patients discharge

  6. Correlation between parameters trend, including persistent deviation from pre-operative values, and patient outcome or length of hospital stay.

    To investigate the incidence of complication and/or prolonged LOS if the patient experience a progressive postoperative deviation from baseline vital parameters.

    Time frame: Untill patient discharge from hospital

  7. Barriers to patient rehabilitation and patients satisfaction

    Investigate whether the wearable device hinders patient rehabilitation, expressed as the percentage of patients reporting a reduced capacity for postoperative early mobilization or rehabilitation, and patients global satisfaction through a questionnaire.

    Time frame: 72 hours after surgery or discharge

07

Study locations

1 of 1 sites recruiting
  • 2^ Anestesia, Rianimazione, Terapia Intensiva - Azienda Ospedaliero Universitaria di Parma
    Parma, Parma 43126, Italy
    Recruiting
08

References and documents

Publications

  • Thompson JS, Baxter BT, Allison JG, Johnson FE, Lee KK, Park WY. Temporal patterns of postoperative complications. Arch Surg. 2003 Jun;138(6):596-602; discussion 602-3. doi: 10.1001/archsurg.138.6.596. PubMed 12799329 ↗
  • Levin N, Horton D, Sanford M, Horne B, Saseendran M, Graves K, White M, Tonna JE. Failure of vital sign normalization is more strongly associated than single measures with mortality and outcomes. Am J Emerg Med. 2020 Dec;38(12):2516-2523. doi: 10.1016/j.ajem.2019.12.024. Epub 2019 Dec 14. PubMed 31864869 ↗
  • Smith GB, Prytherch DR, Meredith P, Schmidt PE, Featherstone PI. The ability of the National Early Warning Score (NEWS) to discriminate patients at risk of early cardiac arrest, unanticipated intensive care unit admission, and death. Resuscitation. 2013 Apr;84(4):465-70. doi: 10.1016/j.resuscitation.2012.12.016. Epub 2013 Jan 4. PubMed 23295778 ↗
  • Bellini V, Brambilla M, Bignami E. Wearable devices for postoperative monitoring in surgical ward and the chain of liability. J Anesth Analg Crit Care. 2024 Mar 7;4(1):19. doi: 10.1186/s44158-024-00154-6. PubMed 38454498 ↗
  • Downey CL, Croft J, Ainsworth G, Buckley H, Shinkins B, Randell R, Brown JM, Jayne DG. Trial of remote continuous versus intermittent NEWS monitoring after major surgery (TRaCINg): a feasibility randomised controlled trial. Pilot Feasibility Stud. 2020 Nov 23;6(1):183. doi: 10.1186/s40814-020-00709-8. PubMed 33292669 ↗
  • Churpek MM, Yuen TC, Park SY, Gibbons R, Edelson DP. Using electronic health record data to develop and validate a prediction model for adverse outcomes in the wards*. Crit Care Med. 2014 Apr;42(4):841-8. doi: 10.1097/CCM.0000000000000038. PubMed 24247472 ↗
  • Nagendran M, Dimick JB, Gonzalez AA, Birkmeyer JD, Ghaferi AA. Mortality Among Older Adults Before Versus After Hospital Transition to Intensivist Staffing. Med Care. 2016 Jan;54(1):67-73. doi: 10.1097/MLR.0000000000000446. PubMed 26492215 ↗
  • van der Stam JA, Mestrom EHJ, Nienhuijs SW, de Hingh IHJT, Boer AK, van Riel NAW, de Groot KTJ, Verhaegh W, Scharnhorst V, Bouwman RA. A wearable patch based remote early warning score (REWS) in major abdominal cancer surgery patients. Eur J Surg Oncol. 2023 Jan;49(1):278-284. doi: 10.1016/j.ejso.2022.08.034. Epub 2022 Sep 2. PubMed 36085116 ↗
  • Lee A, Lum ME, O'Regan WJ, Hillman KM. Early postoperative emergencies requiring an intensive care team intervention. The role of ASA physical status and after-hours surgery. Anaesthesia. 1998 Jun;53(6):529-35. doi: 10.1046/j.1365-2044.1998.00395.x. PubMed 9709136 ↗
  • Khanna AK, Flick M, Saugel B. Continuous vital sign monitoring of patients recovering from surgery on general wards: a narrative review. Br J Anaesth. 2025 Feb;134(2):501-509. doi: 10.1016/j.bja.2024.10.045. Epub 2025 Jan 7. PubMed 39779421 ↗
  • Breteler MJM, KleinJan E, Numan L, Ruurda JP, Van Hillegersberg R, Leenen LPH, Hermans M, Kalkman CJ, Blokhuis TJ. Are current wireless monitoring systems capable of detecting adverse events in high-risk surgical patients? A descriptive study. Injury. 2020 May;51 Suppl 2:S97-S105. doi: 10.1016/j.injury.2019.11.018. Epub 2019 Nov 17. PubMed 31761422 ↗
  • Lam T, Nagappa M, Wong J, Singh M, Wong D, Chung F. Continuous Pulse Oximetry and Capnography Monitoring for Postoperative Respiratory Depression and Adverse Events: A Systematic Review and Meta-analysis. Anesth Analg. 2017 Dec;125(6):2019-2029. doi: 10.1213/ANE.0000000000002557. PubMed 29064874 ↗
  • Stone JG, Cozine KA, Wald A. Nocturnal oxygenation during patient-controlled analgesia. Anesth Analg. 1999 Jul;89(1):104-10. doi: 10.1097/00000539-199907000-00018. PubMed 10389786 ↗
  • Benyamin R, Trescot AM, Datta S, Buenaventura R, Adlaka R, Sehgal N, Glaser SE, Vallejo R. Opioid complications and side effects. Pain Physician. 2008 Mar;11(2 Suppl):S105-20. PubMed 18443635 ↗

Individual participant data

Plan to share: Yes — Raw IPD that underlie results

Supporting information: Study protocol, Statistical analysis plan, Clinical study report

Time frame: At the end of enrollment and data collection

Access criteria: Upon request to the Principal Investigator

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Feb 2026 (actual). Primary completion is estimated for Feb 2027, 12 months after the start.

Of 276 non-industry observational studies under Postoperative Complications, half reached primary completion within 22 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 39. This study's planned 12 months is below that.

Counting every sponsor, half of 281 studies reached it within 22 months; a quarter within 10 and three quarters within 39.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 15, 2026
First posted
Jul 28, 2026
StartActual
Feb 10, 2026
Primary completionEst.
Feb 2027
CompletionEst.
Feb 2027
Last update
Jul 28, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 28, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07729891
Lead sponsor
Azienda Ospedaliero-Universitaria di Parma
Responsible party
Valentina Bellini (Prof., Azienda Ospedaliero-Universitaria di Parma) — Principal investigator
First posted
Jul 28, 2026
Start date
Feb 10, 2026
Primary completion
Feb 2027 (estimated)
Completion
Feb 2027 (estimated)
Last update
Jul 28, 2026

Study contacts

Valentina Bellini
Contact
bellini.vnt@gmail.com
+393388284629
Matteo Panizzi
Contact
matteo.panizzi@unipr.it
+393494156020

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion